Best supportive care for idiopathic pulmonary fibrosis

Current gaps and future directions

Giovanni Ferrara, Fabrizio Luppi, Surinder S. Birring, Stefania Cerri, Antonella Caminati, Magnus Sköld, Michael Kreuter

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.

Original languageEnglish
Article number170076
JournalEuropean Respiratory Review
Volume27
Issue number147
DOIs
Publication statusPublished - Mar 31 2018

Fingerprint

Idiopathic Pulmonary Fibrosis
Quality of Life
Direction compound
Survival
Neoplasms

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Best supportive care for idiopathic pulmonary fibrosis : Current gaps and future directions. / Ferrara, Giovanni; Luppi, Fabrizio; Birring, Surinder S.; Cerri, Stefania; Caminati, Antonella; Sköld, Magnus; Kreuter, Michael.

In: European Respiratory Review, Vol. 27, No. 147, 170076, 31.03.2018.

Research output: Contribution to journalArticle

Ferrara, Giovanni ; Luppi, Fabrizio ; Birring, Surinder S. ; Cerri, Stefania ; Caminati, Antonella ; Sköld, Magnus ; Kreuter, Michael. / Best supportive care for idiopathic pulmonary fibrosis : Current gaps and future directions. In: European Respiratory Review. 2018 ; Vol. 27, No. 147.
@article{8691ef6642cd4e12803ca39c7c19583b,
title = "Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions",
abstract = "Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.",
author = "Giovanni Ferrara and Fabrizio Luppi and Birring, {Surinder S.} and Stefania Cerri and Antonella Caminati and Magnus Sk{\"o}ld and Michael Kreuter",
year = "2018",
month = "3",
day = "31",
doi = "10.1183/16000617.0076-2017",
language = "English",
volume = "27",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "147",

}

TY - JOUR

T1 - Best supportive care for idiopathic pulmonary fibrosis

T2 - Current gaps and future directions

AU - Ferrara, Giovanni

AU - Luppi, Fabrizio

AU - Birring, Surinder S.

AU - Cerri, Stefania

AU - Caminati, Antonella

AU - Sköld, Magnus

AU - Kreuter, Michael

PY - 2018/3/31

Y1 - 2018/3/31

N2 - Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.

AB - Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.

UR - http://www.scopus.com/inward/record.url?scp=85041891339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041891339&partnerID=8YFLogxK

U2 - 10.1183/16000617.0076-2017

DO - 10.1183/16000617.0076-2017

M3 - Article

VL - 27

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 147

M1 - 170076

ER -